Unraveling human intervertebral disc development with stem cells
Active Grant Awarded Last action
- Award ID
- DP2HD125960
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $731,549
Award facts
- Assistance listing
- 93.310 Trans-NIH Research Support
- Completion date 4% complete
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- Baltimore, MD 21205, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, Office of the Director awarded The Johns Hopkins University a grant with $731,549 in obligated funding on September 9, 2026, under Assistance Listing 93.310, Trans-NIH Research Support. Grant DP2HD125960 funds research on human intervertebral disc (IVD) development using human pluripotent stem cells. The recipient will extend an existing organoid model that recapitulates human spine primordia formation, incorporating additional tissues and supporting later stages of spine organogenesis. Investigators will study how gene regulation, cellular dynamics, and tissue mechanics coordinate progenitor initiation, pattern formation, and tissue maturation during IVD formation. Stated objectives include generating insight into human IVD development and identifying targets for novel therapies for disc degeneration. The period of performance runs from the September 9, 2026 award date to an ultimate completion date of May 31, 2031. Work is performed in Baltimore, Maryland 21205. The source identifies no sub-recipients for this award.
Description
- Abstract
- An unfortunate consequence of aging is the gradual decline of tissues and organs. One tissue that tends to deteriorate with advancing age is the intervertebral disc (IVD) of the spine. The degeneration of the IVD serves as the primary cause of low back pain, which has become one of the most common causes of disability worldwide. Unfortunately, due to limited understanding of the IVD, there are no effective treatment strategies to halt or reverse disc degeneration. We aim to advance IVD biology from the perspective of human development. Not only can developmental mechanisms serve as roadmaps for potential therapies to stimulate disc regeneration, but they also provide valuable guidance for engineering efforts to manufacture tissues for disc repair. Progress in the field of IVD development has long been hindered by the lack of tractable and human-specific model systems. To overcome this challenge, we propose to use human pluripotent stem cells (PSC) to establish novel in vitro systems and unravel mechanisms of IVD formation. Excitingly, we have developed an organoid model recapitulating human spine primordia formation, which represents the most advanced system of IVD development derived from human pscs. We will build on this novel system to establish more complex models, by incorporating additional tissues as well as supporting even later stages of spine organogenesis. Leveraging these innovative systems, we will employ multi-disciplinary approaches to investigate how gene regulation, cellular dynamics, and tissue mechanics coordinate to control critical aspects of IVD formation, including progenitor initiation, pattern formation, and tissue maturation. The proposed work represents a major departure from traditional approaches and perspectives in the field. IT will generate comprehensive insights into human IVD development, pointing to potential targets for novel therapies aimed at restoring disc properties. IT offers innovative platforms to not only transform the field of IVD development but also advance multiple other fronts. Cells and tissues generated in this work can be further combined with engineering platforms to model disease progression and accelerate drug discovery. Together, the proposed project will have a broad impact on understanding human development and treating aging-associated degenerative diseases.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $731,549 |
Quick answers
Who received award DP2HD125960?
DP2HD125960 was awarded to The Johns Hopkins University by National Institute of Child Health and Human Development (National Institutes of Health) on September 9, 2026.
How much is award DP2HD125960 worth?
$731,549 has been obligated on DP2HD125960.
Which agency awarded DP2HD125960?
National Institute of Child Health and Human Development (National Institutes of Health) awarded DP2HD125960, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award